← All Sponsors
SPONSOR

Sumitomo Pharma America, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Solid Tumor
NCT06526819 Phase 1, Phase 2
Recruiting

SMP-3124LP in Adults With Advanced Solid Tumors

Solid Tumor
United States, Japan View Trial →